Incyte (INCY) EPS (Weighted Average and Diluted) Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -82.39% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -97.49% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 61.45% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -7.15% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,178.57% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 83.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.75% |
| Dec 31, 2025 | 53.68% |
| Sep 30, 2025 | 290.74% |
| Jun 30, 2025 | 200.00% |
| Mar 31, 2025 | 6.67% |
| Dec 31, 2024 | 6.74% |
| Sep 30, 2024 | -28.95% |
| Jun 30, 2024 | -326.67% |
| Mar 31, 2024 | 650.00% |
| Dec 31, 2023 | 641.67% |
| Sep 30, 2023 | 52.00% |
| Jun 30, 2023 | 25.00% |
| Mar 31, 2023 | -41.18% |
| Dec 31, 2022 | -95.28% |
| Sep 30, 2022 | -39.02% |
| Jun 30, 2022 | 7.46% |
| Mar 31, 2022 | -29.17% |
| Dec 31, 2021 | 273.53% |
| Sep 30, 2021 | 1,271.43% |
| Jun 30, 2021 | -49.24% |
| Mar 31, 2021 | 107.21% |
| Dec 31, 2020 | 33.33% |
| Sep 30, 2020 | -111.86% |
| Jun 30, 2020 | 175.00% |
| Mar 31, 2020 | -808.51% |
| Dec 31, 2019 | 59.38% |
| Sep 30, 2019 | 321.43% |
| Jun 30, 2019 | 100.00% |
| Mar 31, 2019 | 347.37% |
| Dec 31, 2018 | 145.07% |
| Sep 30, 2018 | -17.65% |
| Jun 30, 2018 | 500.00% |
| Mar 31, 2018 | 80.21% |
| Dec 31, 2017 | -1,520.00% |
| Sep 30, 2017 | -10.53% |
| Jun 30, 2017 | -133.33% |
| Mar 31, 2017 | -900.00% |
| Dec 31, 2016 | -82.76% |
| Sep 30, 2016 | 186.36% |
| Jun 30, 2016 | 260.00% |
| Mar 31, 2016 | 209.09% |
| Dec 31, 2015 | 231.82% |
| Sep 30, 2015 | -166.67% |
| Jun 30, 2015 | 122.73% |
| Mar 31, 2015 | 47.62% |
| Dec 31, 2014 | 21.43% |
| Sep 30, 2014 | 335.71% |
| Jun 30, 2014 | -1,000.00% |
| Jun 30, 2013 | -166.67% |
| Jun 30, 2012 | 107.32% |
| Mar 31, 2012 | -70.05% |
| Dec 31, 2011 | -264.22% |
| Sep 30, 2011 | -63.64% |
| Jun 30, 2011 | -2,150.00% |
| Mar 31, 2011 | 30.00% |